Spacer prostheses in two-stage revision of infected knee arthroplasty

E Jämsen, P Sheng, P Halonen, M U K Lehto, T Moilanen, J Pajamäki, T Puolakka, Y T Konttinen, E Jämsen, P Sheng, P Halonen, M U K Lehto, T Moilanen, J Pajamäki, T Puolakka, Y T Konttinen

Abstract

At present, no consensus exists on the best spacer alternative for the management of two-stage exchange arthroplasty of infected knee arthroplasties. In this retrospective study, patient records of 24 patients, who had undergone two-stage revisions in which resterilised prosthetic components were used as spacers, were reviewed. The outcome was compared to that of operations performed during the same period (1993-2003) using cement spacers (n=10). With an average follow-up of 32 months, control of infection was achieved in 26 cases (76%), with good or excellent clinical outcome in 19 cases (56%). Treatment failed and resulted in amputation at the level of the thigh before reimplantation in one case. Three patients did not undergo reimplantation. In four cases (12%) infection relapsed. The reinfection rate did not differ between the two spacer groups. Patients treated with resterilised components had a superior range of motion during the period between the two stages. Operative time was shorter and there was less blood loss in the reimplantation arthroplasty when a prosthetic spacer was used. We consider resterilised prosthetic components a safe and effective alternative to cement spacers in the management of infected knee arthroplasties.

Figures

Fig. 1
Fig. 1
Treatment and outcome in the eradication of infection with the use of resterilised prosthesis spacer and cement spacer

Source: PubMed

3
구독하다